In this study, we profiled and analyzed OR cells generated from two BRCA1/2 mutant breast cancer cell lines at the transcriptome, proteome, ADP-ribosylome, and phosphoproteome levels to investigate the changes they undergo when they acquire Olaparib resistance. This evidence concerns the gene BRCA1 and breast cancer.